Hui ZhangExecutive Director, Digital Office at Eli Lilly & Co.Speaker
Agenda Sessions
Context of Use for Wearable Technology – Establishing a Digital Biomarker as a Recognized End Point for Clinical Development
, 09:30View SessionContext of Use for Wearable Technology – Establishing a Digital Biomarker as a Recognized End Point for Clinical Development
, 09:30View SessionPANEL: Trying to Define what AI Actually Means in Clinical Trials
, 12:15View Session